- 63
- 27 305
Clario
เข้าร่วมเมื่อ 18 ม.ค. 2023
Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives.
Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory approvals for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.
Visit clario.com/ for more information.
Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory approvals for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years.
Visit clario.com/ for more information.
วีดีโอ
Optimizing Obesity Trials
มุมมอง 337หลายเดือนก่อน
Integrating Diverse Endpoints to Holistically Assess Safety and Efficacy of GLP-1 Agonists and Beyond
Digital Endpoint Solutions to Extract the Most Value from Your Clinical Study
มุมมอง 86หลายเดือนก่อน
Watch our webinar replay to explore how digital endpoint solutions accelerate breakthroughs in psychiatric drug development. Learn how electronic clinical outcome assessments (eCOA), medical imaging, and cardiac safety monitoring enhance trial accuracy, improve patient experience, and drive innovation in psychiatric clinical trials. Discover the impact of cutting-edge technologies on advancing ...
Advancing MS Clinical Trials
มุมมอง 1003 หลายเดือนก่อน
Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes
Neuroscience studies: Clario's approach
มุมมอง 1803 หลายเดือนก่อน
Clario: Your partner in neuroscience clinical trials Are you developing life-changing drugs? With decades of experience and over 5,000 neuroscience studies, Clario can help you answer critical questions about your drug's efficacy, safety, and impact on quality of life. Our global neuroscience experts offer tailored strategies, precise data, and outcome assessments to minimize risks, avoid delay...
Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility & Advanced AI Analysis
มุมมอง 1035 หลายเดือนก่อน
Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility & Advanced AI Analysis
Advancing Alzheimer’s Clinical Trial Endpoints
มุมมอง 1166 หลายเดือนก่อน
Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk This webinar explores the critical aspects of conducting clinical trials in Alzheimer's disease (AD) with a focus on innovative methodologies and challenges encountered. We will review the pivotal role of imaging biomarkers in characterizing patient eligibility, ensuring safety and evaluating therapeutic efficacy in AD trials. N...
A Holistic Approach to Parkinson’s Disease Endpoint Data Collection
มุมมอง 2466 หลายเดือนก่อน
In this webinar replay, the expert speakers will comprehensively explore Parkinson’s disease endpoint data collection, where they will delve into the crucial elements of efficacy, safety and quality of life. The webinar will highlight the revolutionary Opal wearable solution and its important role in providing quantitative gait assessments, thus offering a better understanding of disease progre...
Going Beyond ATS ERS 2019 Guidelines for Your Respiratory Clinical Trials
มุมมอง 2307 หลายเดือนก่อน
Watch this insightful webinar in which the expert speakers will explore the evolution of data quality assessments in respiratory drug development. Historically, adherence to enforced spirometry standards from the American Thoracic Society (ATS)/European Respiratory Society (ERS) guidelines has been the acceptable measure of high-quality data. However, despite refinements made in 2019 to address...
New Frontiers in Respiratory Trials: AI, Lung Sounds, Remote Coaching and Alternate Endpoints
มุมมอง 1207 หลายเดือนก่อน
In this webinar, Dr. Marko Topalović, co-founder of ArtiQ, will discuss new artificial intelligence approaches to spirometry data overread that enable instant feedback and make at-home testing more robust and cost-effective. Clario’s Kevin McCarthy and Dr. Phil Lake will address new options for at-home spirometry that bring the clinician into the participant’s home, virtually, and the impact th...
Benefits of Utilizing Early Precision QT and Artificial Intelligence-Powered Data Quality Assessment
มุมมอง 1248 หลายเดือนก่อน
Benefits of Utilizing Early Precision QT and Artificial Intelligence-Powered Data Quality Assessment
Cutting Edge Data Reveals Improved Sensitivity of PD Motor Progression with Wearable Sensors
มุมมอง 6669 หลายเดือนก่อน
Cutting Edge Data Reveals Improved Sensitivity of PD Motor Progression with Wearable Sensors
Clinical Trials of Schizophrenia: Optimizing PROs and PerfOs
มุมมอง 669 หลายเดือนก่อน
In schizophrenia trials, clinical outcome assessments (COAs) are traditionally clinician reported outcomes (ClinRO). However, there is growing recognition that patient reported and patient performance data contributes valuable information to such studies. Join Clario (previously ERT) and Cogstate for “Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome...
Responsibly Advancing the Use of AI in Clinical Trials
มุมมอง 10K9 หลายเดือนก่อน
Current Landscape, Common Misconceptions and Future Opportunities
Clario Rater Participant and Caregiver Training
มุมมอง 1.1K11 หลายเดือนก่อน
Clario Rater Participant and Caregiver Training
Integrating Objectively Measured Safety Endpoints and Patient Reported Outcomes in Oncology Trials
มุมมอง 151ปีที่แล้ว
Integrating Objectively Measured Safety Endpoints and Patient Reported Outcomes in Oncology Trials
Using Scientific Validation to Move the Needle on Accessibility Functionalities Webinar
มุมมอง 112ปีที่แล้ว
Using Scientific Validation to Move the Needle on Accessibility Functionalities Webinar
Revolutionizing Oncology Clinical Trials Webinar
มุมมอง 391ปีที่แล้ว
Revolutionizing Oncology Clinical Trials Webinar
Accurate Suicide Risk Detection with eC SSRS Helps Ensure Safety of Trial Participants and Treatment
มุมมอง 224ปีที่แล้ว
Accurate Suicide Risk Detection with eC SSRS Helps Ensure Safety of Trial Participants and Treatment
Updates in regulatory guidelines for blood pressure monitoring in clinical trials
มุมมอง 198ปีที่แล้ว
Updates in regulatory guidelines for blood pressure monitoring in clinical trials
Forbes Healthcare Vision 2030 - A Glimpse Into The Future | Clario
มุมมอง 117ปีที่แล้ว
Forbes Healthcare Vision 2030 - A Glimpse Into The Future | Clario
New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
มุมมอง 194ปีที่แล้ว
New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
Safety and Tolerability in Oncology Trials: Cardiac Imaging, ECG, and Patient-Reported Outcomes
มุมมอง 128ปีที่แล้ว
Safety and Tolerability in Oncology Trials: Cardiac Imaging, ECG, and Patient-Reported Outcomes
CNS and Chronic Drug Trials: New Cardiac Safety Requirements
มุมมอง 69ปีที่แล้ว
CNS and Chronic Drug Trials: New Cardiac Safety Requirements
Innovation and Disruption Leaders | CBS News | Clario
มุมมอง 150ปีที่แล้ว
Innovation and Disruption Leaders | CBS News | Clario
Parkinsonian Symptoms - Capturing a Comprehensive Picture with Fit-for-Purpose Assessments
มุมมอง 59ปีที่แล้ว
Parkinsonian Symptoms - Capturing a Comprehensive Picture with Fit-for-Purpose Assessments
Dr. Kelly Posner shares her thoughts on C-SSRS
มุมมอง 248ปีที่แล้ว
Dr. Kelly Posner shares her thoughts on C-SSRS
Stay clear of this disgusting filthy company. They recently had a drag queen in to talk about how he use to strip and perform s3x acts for money. How he loves putting on shows for kids. They believe men can be women. This is a nasty disgusting company.
Stay clear of this disgusting filthy company. They recently had a drag queen in to talk about how he use to strip and perform s3x acts for money. How he loves putting on shows for kids. They believe men can be women. This is a nasty disgusting company.
Stay clear of this disgusting filthy company. They recently had a drag queen in to talk about how he use to strip and perform s3x acts for money. How he loves putting on shows for kids. They believe men can be women. This is a nasty disgusting company.
Stay clear of this disgusting filthy company. They recently had a drag queen in to talk about how he use to strip and perform s3x acts for money. How he loves putting on shows for kids. They believe men can be women. This is a nasty disgusting company.
Stay clear of this disgusting filthy company. They recently had a drag queen in to talk about how he use to strip and perform s3x acts for money. How he loves putting on shows for kids. They believe men can be women. This is a nasty disgusting company. Stay away
"promosm" 🤔